We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+4.86%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$667B
AUM Growth
-$78.5B
Cap. Flow
-$15B
Cap. Flow %
-2.25%
Top 10 Hldgs %
32.39%
Holding
14,586
New
1,953
Increased
4,555
Reduced
6,197
Closed
1,571

Top Buys

Rank Stock Value
1
C icon
Citigroup
C
+$1.13B
2
T icon
AT&T
T
+$275M
3
AAPL icon
Apple
AAPL
+$248M
4
DIS icon
Walt Disney
DIS
+$235M
5
NKE icon
Nike
NKE
+$195M

Sector Composition

Rank Sector Weight
1 Miscellaneous 92.82%
2 Technology 1.6%
3 Consumer Discretionary 1.3%
4 Financials 0.99%
5 Communication Services 0.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TYME
12301
PUT
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$72K ﹤0.01%
120,800
-268,300
-69% -$231K
MILE
12302
CALL
DELISTED
Metromile, Inc. Common Stock
MILE
$72K ﹤0.01%
33,000
-137,100
-81% -$391K
ENLV icon
12303
Enlivex Ltd
ENLV
$25.9M
$71K ﹤0.01%
+752
New +$88.5K
LUCD icon
12304
Lucid Diagnostics
LUCD
$188M
$71K ﹤0.01%
+13,255
New +$108K
NNVC icon
12305
PUT
NanoViricides
NNVC
$32.7M
$71K ﹤0.01%
19,100
-23,700
-55% -$108K
NTIP icon
12306
Network-1 Technologies
NTIP
$35.2M
$71K ﹤0.01%
+25,353
New +$72.4K
PMCB icon
12307
PUT
PharmaCyte Biotech
PMCB
$5.8M
$71K ﹤0.01%
+28,500
New +$78.5K
XNET
12308
Xunlei
XNET
$319M
$71K ﹤0.01%
35,221
+15,405
+78% +$40.4K
YCBD icon
12309
cbdMD
YCBD
$5.57M
$71K ﹤0.01%
182
-88
-33% -$51.2K
VLD.WS
12310
DELISTED
Velo3D, Inc. Redeemable warrants, each Warrant exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50
VLD.WS
$71K ﹤0.01%
+42,642
New +$91.9K
TLIS
12311
PUT
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
$71K ﹤0.01%
1,180
-1,260
-52% -$94.3K
VIEW
12312
DELISTED
View, Inc. Class A Common Stock
VIEW
$71K ﹤0.01%
301
-1,668
-85% -$479K
AMPE
12313
PUT
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$71K ﹤0.01%
413
+243
+143% +$90.6K
AEMD icon
12314
PUT
Aethlon Medical
AEMD
$1.54M
$70K ﹤0.01%
9
-3
-25% -$34.2K
AVTX icon
12315
PUT
Avalo Therapeutics
AVTX
$1.08B
$70K ﹤0.01%
14
-12
-46% -$72K
CECO icon
12316
Ceco Environmental
CECO
$4.23B
$70K ﹤0.01%
11,160
-5,069
-31% -$33.6K
BGMS
12317
Bio Green Med Solution Inc
BGMS
$5.9M
$70K ﹤0.01%
5
+1
+25% +$16.1K
GNE icon
12318
Genie Energy
GNE
$392M
$70K ﹤0.01%
+12,648
New +$69.9K
VOC icon
12319
CALL
VOC Energy
VOC
$55.6M
$70K ﹤0.01%
15,000
-74,300
-83% -$358K
WKSP icon
12320
Worksport
WKSP
$9.64M
$70K ﹤0.01%
+2,908
New +$130K
NOVN
12321
DELISTED
Novan, Inc. Common Stock
NOVN
$70K ﹤0.01%
+16,709
New +$100K
EXTN
12322
CALL
DELISTED
Exterran Corporation
EXTN
$70K ﹤0.01%
23,600
+3,100
+15% +$12.3K
BKYI
12323
CALL
BIO-key International
BKYI
$4.45M
$69K ﹤0.01%
175
+57
+48% +$28.8K
DHY
12324
Credit Suisse High Yield Credit Fund
DHY
$236M
$69K ﹤0.01%
+28,095
New +$69.7K
DPRO
12325
CALL
Draganfly
DPRO
$162M
$69K ﹤0.01%
1,700
-1,084
-39% -$76.9K

Similar funds

Jeff Yass's Q4 2021 Portfolio in Review

As of Q4 2021, Jeff Yass held 14,586 positions worth $667B, down 11% from $745B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Jeff Yass's Q4 2021 filing shows 1,953 new, 4,555 increased, 6,197 reduced and 1,571 closed positions. Its largest new stake was iShares Core MSCI Emerging Markets ETF: 1,306,619 shares worth $78.2M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.4B.

By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q4 2021 buy was iShares Core MSCI Emerging Markets ETF: 1,306,619 shares worth $78.2M.
  • Jeff Yass added most to Citigroup in Q4 2021, an estimated $1.13B increase.
  • Jeff Yass's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.4B.
  • Jeff Yass fully exited Stamps.com, Inc. in Q4 2021, selling an estimated $78.8M.
  • Jeff Yass's ten largest holdings make up 32% of its $667B portfolio in Q4 2021.
  • Jeff Yass opened 1,953 new positions and closed 1,571 in Q4 2021.
  • Jeff Yass's portfolio value fell 11% quarter-over-quarter to $667B.

Based on Susquehanna International Group's 13F filing for Q4 2021, filed 14 Feb 2022.